Vir Biotechnology, Inc.
VIR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001706431
No open-market purchases or sales by Vir Biotechnology, Inc. insiders were filed in the last 90 days; 237 institutions reported holding it in 13F filings for Q2 2026, worth $1.49B in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Vir Biotechnology, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Vir Biotechnology, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| More Robert J | Director | 517,917Indirect | Aug 12, 2026 | 2 |
| Coughlin Timothy | Director | 16,000 | Jun 10, 2026 | 1 |
| Napolitano Janet | Director | 21,216 | Jun 2, 2026 | 2 |
| Sabatini Brent | SVP, Chief Accounting Officer | 61,902 | Jun 2, 2026 | 5 |
| Bischofberger Norbert W | Director | 21,333 | May 28, 2026 | 1 |
| Hatfield Jeffrey S. | Director | 39,806 | May 28, 2026 | 1 |
| Sigal Charles Elliott | Director | 39,806 | May 28, 2026 | 1 |
| Farid Ramy | Director | 32,000 | May 28, 2026 | 1 |
| Sato Vicki L | Director | 1,078,391 | May 4, 2026 | 9 |
| De Backer Marianne | President and CEO | 286,650Indirect | Apr 30, 2026 | 4 |
| O'Byrne Jason | EVP & Chief Financial Officer | 2,500Indirect | Mar 23, 2026 | 4 |
| Eisner Mark | EVP and Chief Medical Officer | 154,024 | Feb 26, 2026 | 2 |
| de Verneuil Vanina | EVP, General Counsel, Corp Sec | 112,982 | Feb 26, 2026 | 4 |
| SB Investment Advisers (UK) Ltd | 10% Owner | 13,728,924Indirect | Dec 3, 2025 | 11 |
| Softbank Vision Fund (Aiv M1) L.P. | 10% Owner | 13,728,924Indirect | Dec 3, 2025 | 11 |
| SVF Endurance (Cayman) Ltd | 10% Owner | 13,728,924Indirect | Dec 3, 2025 | 11 |
| Ramasastry Saira | Director | 22,619 | Jun 2, 2025 | 0 |
| Scangos George A | Director | 698,239 | Feb 25, 2025 | 0 |
| Hanly Ann M. | EVP & Chief Technology Officer | 117,901 | Feb 25, 2025 | 0 |
| Nelsen Robert | Director | 584,148 | Jun 3, 2024 | 0 |
| Lee Sung | EVP & Chief Financial Officer | 100,492 | Mar 28, 2024 | 0 |
| Pang Phillip | EVP & Chief Medical Officer | 250,111 | Feb 26, 2024 | 0 |
| Rice Steven J. | Chief Administrative Officer | 106,840 | Jun 2, 2023 | 0 |
| Sharp Phillip A | Director | 121,174 | May 24, 2023 | 0 |
| Perez Robert J | Director | 15,806 | May 24, 2023 | 0 |
| Friedl-Naderer Johanna | EVP & Chief Operating Officer | 148,518 | Mar 7, 2023 | 0 |
| Horn Howard | CFO | 230,712 | Feb 24, 2023 | 0 |
| Crandell Keith | 10% Owner | 61,160Indirect | Sep 7, 2022 | 0 |
| Bybee Clinton | 10% Owner | 61,160Indirect | Sep 7, 2022 | 0 |
| ARCH Venture Fund IX, L.P. | 10% Owner | 61,160Indirect | Sep 7, 2022 | 0 |
| ARCH Venture Fund IX Overage, L.P. | 10% Owner | 61,160Indirect | Sep 7, 2022 | 0 |
| ARCH Venture Partners IX Overage, L.P. | 10% Owner | 61,160Indirect | Sep 7, 2022 | 0 |
| ARCH Venture Partners IX, L.P. | 10% Owner | 61,160Indirect | Sep 7, 2022 | 0 |
| ARCH Venture Partners IX, LLC | 10% Owner | 61,160Indirect | Sep 7, 2022 | 0 |
| Virgin Herbert | EVP, Research & CSO | 262,500 | Aug 10, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 9, 2023 (view filing)9:00 PM ET | Feb 7-8 | 2 days | SB Investment Advisers (UK) Ltd and 2 others10% Owner | SSale | −145.4K | $28.51 | −$4.15M | −0.8%18.8M after | 5 lots |
| Feb 13, 2023 (view filing)9:00 PM ET | Feb 9-10 | 4 days | SB Investment Advisers (UK) Ltd and 2 others10% Owner | SSale | −234.3K | $26.28 | −$6.16M | −1.2%18.6M after | 5 lots |
| Feb 15, 2023 (view filing)9:00 PM ET | Feb 13-14 | 2 days | SB Investment Advisers (UK) Ltd and 2 others10% Owner | SSale | −118.0K | $26.28 | −$3.10M | −0.6%18.4M after | 3 lots |
| Feb 17, 2023 (view filing)9:00 PM ET | Feb 15 | 2 days | SB Investment Advisers (UK) Ltd and 2 others10% Owner | SSale | −39.0K | $26.75 | −$1.04M | −0.2%18.4M after | |
| Feb 21, 2023 (view filing) | Feb 17 | 4 days | Horn HowardCFO | SSale | −2.42K | $25.29 | −$61.3K | −1.0%233.0K after | |
| Feb 21, 2023 (view filing) | Feb 17 | 4 days | Pang PhillipChief Medical Officer | SSale | −2.80K | $25.29 | −$70.9K | −1.9%141.2K after | |
| Feb 21, 2023 (view filing) | Feb 17 | 4 days | Rice Steven J.Chief Administrative Officer | SSale | −1.98K | $25.29 | −$50.1K | −5.1%37.2K after | |
| Feb 21, 2023 (view filing) | Feb 17-21 | 4 days | Scangos George APresident and CEO | SSale | −27.8K | $27.23 | −$755.6K | −12.4%196.2K after | 3 lots |
| Feb 23, 2023 (view filing)9:00 PM ET | Feb 21 | 2 days | SB Investment Advisers (UK) Ltd and 2 others10% Owner | SSale | −74.5K | $28.43 | −$2.12M | −0.4%18.3M after | 4 lots |
| Feb 24, 2023 (view filing) | Feb 23 | 1 day | Rice Steven J.Chief Administrative Officer | SSale | −1.79K | $25.97 | −$46.6K | −1.6%108.4K after | |
| Feb 24, 2023 (view filing) | Feb 23 | 1 day | Pang PhillipChief Medical Officer | SSale | −2.88K | $25.97 | −$74.7K | −1.4%198.3K after | |
| Feb 24, 2023 (view filing) | Feb 23-24 | 1 day | Scangos George APresident and CEO | SSale | −27.8K | $24.53 | −$680.8K | −14.1%168.5K after | 3 lots |
| Feb 24, 2023 (view filing) | Feb 23 | 1 day | Hanly Ann M.Chief Technology Officer | SSale | −2.30K | $25.97 | −$59.8K | −1.9%117.2K after | |
| Feb 24, 2023 (view filing) | Feb 23 | 1 day | Horn HowardCFO | SSale | −2.25K | $25.97 | −$58.4K | −1.0%230.7K after | |
| Feb 28, 2023 (view filing) | Feb 27 | 1 day | Pang PhillipChief Medical Officer | SSale | −10.3K | $23.08 | −$238.1K | −5.2%188.0K after | 2 lots |
| Mar 2, 2023 (view filing) | Mar 1 | 1 day | Sigal Charles ElliottDirector | PPurchase | +2.50K | $22.73 | +$56.8K | +33.3%10.0K after | |
| Mar 7, 2023 (view filing) | Mar 3 | 4 days | Friedl-Naderer JohannaEVP & Chief Operating Officer | SSale | −1.48K | $22.82 | −$33.8K | −1.0%148.5K after | |
| Mar 9, 2023 (view filing) | Mar 8 | 1 day | Sato Vicki LDirector | SSale | −17.9K | $22.59 | −$405.2K | −1.3%1.33M after | |
| Mar 31, 2023 (view filing) | Mar 30 | 1 day | Hanly Ann M.Chief Technology Officer | SSale | −2.63K | $22.77 | −$59.8K | −2.2%114.6K after | |
| Apr 18, 2023 (view filing)9:00 PM ET | Apr 14-17 | 4 days | SB Investment Advisers (UK) Ltd and 2 others10% Owner | SSale | −20.1K | $25.08 | −$503.9K | −0.1%18.3M after | 2 lots |
| Apr 20, 2023 (view filing)9:00 PM ET | Apr 18-19 | 2 days | SB Investment Advisers (UK) Ltd and 2 others10% Owner | SSale | −83.1K | $25.12 | −$2.09M | −0.5%18.2M after | 2 lots |
| Apr 24, 2023 (view filing)9:00 PM ET | Apr 20-21 | 4 days | SB Investment Advisers (UK) Ltd and 2 others10% Owner | SSale | −312.0K | $25.76 | −$8.04M | −1.7%17.9M after | 3 lots |
| Apr 26, 2023 (view filing)9:00 PM ET | Apr 24-25 | 2 days | SB Investment Advisers (UK) Ltd and 2 others10% Owner | SSale | −67.0K | $25.42 | −$1.70M | −0.4%17.8M after | 2 lots |
| May 3, 2023 (view filing)9:00 PM ET | May 1 | 2 days | SB Investment Advisers (UK) Ltd and 2 others10% Owner | SSale | −3.08K | $25.30 | −$77.8K | 0.0%17.8M after | |
| May 5, 2023 (view filing)9:00 PM ET | May 3-4 | 2 days | SB Investment Advisers (UK) Ltd and 2 others10% Owner | SSale | −198.0K | $25.53 | −$5.06M | −1.1%17.6M after | 2 lots |
| May 9, 2023 (view filing)9:00 PM ET | May 5 | 4 days | SB Investment Advisers (UK) Ltd and 2 others10% Owner | SSale | −136 | $25.10 | −$3.41K | 0.0%17.6M after | |
| May 23, 2023 (view filing)9:00 PM ET | May 19-22 | 4 days | SB Investment Advisers (UK) Ltd and 2 others10% Owner | SSale | −183.5K | $25.55 | −$4.69M | −1.0%17.5M after | 2 lots |
| May 25, 2023 (view filing)9:00 PM ET | May 23-24 | 2 days | SB Investment Advisers (UK) Ltd and 2 others10% Owner | SSale | −274.5K | $26.46 | −$7.26M | −1.6%17.2M after | 6 lots |
| Jun 2, 2023 (view filing) | Jun 1 | 1 day | Ramasastry SairaDirector | SSale | −3.50K | $25.67 | −$89.8K | −24.8%10.6K after | 10b5-1 |
| Jun 2, 2023 (view filing) | Jun 1 | 1 day | Rice Steven J.Chief Administrative Officer | SSale | −2.50K | $25.67 | −$64.2K | −2.3%106.8K after | 10b5-1 |
| Jun 6, 2023 (view filing)9:00 PM ET | Jun 2-5 | 4 days | SB Investment Advisers (UK) Ltd and 2 others10% Owner | SSale | −39.6K | $27.32 | −$1.08M | −0.2%17.1M after | 2 lots |
| Jun 8, 2023 (view filing) | Jun 7 | 1 day | Pang PhillipChief Medical Officer | SSale | −5.00K | $25.95 | −$129.8K | −2.6%188.0K after | 10b5-1 |
| Jun 15, 2023 (view filing)9:00 PM ET | Jun 13-14 | 2 days | SB Investment Advisers (UK) Ltd and 2 others10% Owner | SSale | −164.1K | $26.75 | −$4.39M | −1.0%17.0M after | 4 lots |
| Jun 20, 2023 (view filing)9:00 PM ET | Jun 15-16 | 5 days | SB Investment Advisers (UK) Ltd and 2 others10% Owner | SSale | −183.3K | $25.56 | −$4.69M | −1.1%16.8M after | 4 lots |
| Jun 22, 2023 (view filing)9:00 PM ET | Jun 20 | 2 days | SB Investment Advisers (UK) Ltd and 2 others10% Owner | SSale | −9.90K | $25.18 | −$249.3K | −0.1%16.8M after | |
| Jun 30, 2023 (view filing)9:00 PM ET | Jun 28-29 | 2 days | SB Investment Advisers (UK) Ltd and 2 others10% Owner | SSale | −97.0K | $25.17 | −$2.44M | −0.6%16.7M after | 2 lots |
| Jul 3, 2023 (view filing) | Jun 30 | 3 days | Sato Vicki LDirector | SSale | −18.0K | $24.66 | −$443.9K | −1.3%1.32M after | 10b5-1 |
| Jul 5, 2023 (view filing)9:00 PM ET | Jun 30 | 5 days | SB Investment Advisers (UK) Ltd and 2 others10% Owner | SSale | −700 | $25.11 | −$17.6K | 0.0%16.7M after | |
| Feb 16, 2024 (view filing) | Feb 16 | Same day | Pang PhillipEVP & Chief Medical Officer | SSale | −3.32K | $10.24 | −$34.0K | −1.2%264.7K after | 10b5-1 |
| Feb 20, 2024 (view filing) | Feb 16-20 | 4 days | Scangos George ADirector | SSale | −27.8K | $10.23 | −$283.8K | −16.5%140.7K after | 2 lots10b5-1 |
| Feb 26, 2024 (view filing) | Feb 22-26 | 4 days | Scangos George ADirector | SSale | −27.8K | $11.07 | −$307.2K | −19.7%113.0K after | 2 lots10b5-1 |
| Feb 26, 2024 (view filing) | Feb 22 | 4 days | Pang PhillipEVP & Chief Medical Officer | SSale | −14.6K | $10.05 | −$146.4K | −5.5%250.1K after | 10b5-1 |
| Feb 26, 2024 (view filing) | Feb 22 | 4 days | Hanly Ann M.EVP & Chief Technology Officer | SSale | −12.3K | $10.05 | −$123.6K | −8.4%134.8K after | 10b5-1 |
| Mar 28, 2024 (view filing) | Mar 27 | 1 day | Lee SungEVP & Chief Financial Officer | SSale | −6.01K | $9.89 | −$59.4K | −5.6%100.5K after | |
| Apr 2, 2024 (view filing) | Apr 1 | 1 day | Hanly Ann M.EVP & Chief Technology Officer | SSale | −2.71K | $10.05 | −$27.2K | −2.0%132.1K after | 10b5-1 |
| Apr 4, 2024 (view filing) | Apr 3 | 1 day | De Backer MarianneChief Executive Officer | SSale | −73.0K | $9.46 | −$690.5K | −9.7%678.5K after | 10b5-1 |
| Jun 12, 2024 (view filing) | Jun 11 | 1 day | Ramasastry SairaDirector | SSale | −4.00K | $10.95 | −$43.8K | −21.5%14.6K after | |
| Sep 10, 2024 (view filing) | Sep 9 | 1 day | Napolitano JanetDirector | SSale | −12.2K | $7.80 | −$95.1K | −51.2%11.6K after | 10b5-1 |
| Nov 5, 2024 (view filing) | Nov 1-5 | 4 days | de Verneuil VaninaEVP and General Counsel | SSale | −3.75K | $8.62 | −$32.3K | −5.8%61.4K after | 2 lots10b5-1 |
| Nov 7, 2024 (view filing) | Nov 6 | 1 day | de Verneuil VaninaEVP and General Counsel | SSale | −4.40K | $10.11 | −$44.5K | −7.2%57.0K after | 10b5-1 |